China, Sept. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Severe bilateral corneal epitheliopathy after the first treatment cycle of trastuzumab... Read More
China, Sept. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Single-Arm, Exploratory, Phase II Clinical Study of Trastuzumab Rezeteccan Combined ... Read More
China, Sept. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Long-Term Outcomes and Side Effects of Helical Tomotherapy for Nasopharyngeal Cancer'.... Read More
China, Sept. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the Role and Mechanism of Gut Microbiota in Moxibustion Treatment of Insomnia... Read More
China, Sept. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Research on the Prevention of VTE with Atoxaban'. The following are the other relevant... Read More
China, Sept. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Multimodal Mechanisms and Prediction of Perioperative Neurocognitive Disorders in Park... Read More
China, Sept. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical study of KCd in the treatment of R/R POEMS syndrome'. The following are the o... Read More
China, Sept. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Population Health Sub Health Disease Data Mining Based on Dynamic System Theory'. The ... Read More
China, Sept. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The Relationship Between Preoperative Quantitative Ultrasound Analysis of Quadriceps a... Read More
China, Sept. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Clinical Study of Polatuzumab Vedotin-Based Combination Regimen for Low-Risk Large B... Read More